Gioacchino Natoli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Venues

Molecular systems biology

The EMBO journal

Science advances

Nature structural & molecular biology

Istituto Europeo di Oncologia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Europeo di Oncologia

Italy

Group Leader :: Department of Experimental Oncology

Humanitas University Jul 01 2016 - Dec 31 2019

Italy

Professor of Biochemistry

Institute for research in biomedicine (IRB)

Switzerland

Group Leader

University of California San Diego

United States

Postdoctoral fellow :: Department of Pharmacology

Publications

Alice Cortesi, Francesco Gandolfi, Fabiana Arco, Pierluigi Di Chiaro, Emanuele Valli, Sara Polletti, Roberta Noberini, Francesco Gualdrini, Sergio Attanasio, Francesca Citron, I-Lin Ho, Rutvi Shah, Er-Yen Yen, Mara Cetty Spinella, Simona Ronzoni, Simona Rodighiero, Nico Mitro, Tiziana Bonaldi, Serena Ghisletti, Silvia Monticelli, Andrea Viale, Giuseppe Riccardo Diaferia, Gioacchino Natoli
Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer. Science advances 10 (13) (2024)
Alice Cortesi, Francesco Gandolfi, Fabiana Arco, Pierluigi Di Chiaro, Emanuele Valli, Sara Polletti, Roberta Noberini, Francesco Gualdrini, Sergio Attanasio, Francesca Citron, I-Lin Ho, Rutvi Shah, Er-Yen Yen, Mara Cetty Spinella, Simona Ronzoni, Simona Rodighiero, Nico Mitro, Tiziana Bonaldi, Serena Ghisletti, Silvia Monticelli, Andrea Viale, Giuseppe Riccardo Diaferia, Gioacchino Natoli
Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer. Science advances 10 (13) (2024)
Francesco Gualdrini, Stefano Rizzieri, Sara Polletti, Francesco Pileri, Yinxiu Zhan, Alessandro Cuomo, Gioacchino Natoli
An integrative epigenome-based strategy for unbiased functional profiling of clinical kinase inhibitors. Molecular systems biology 20 (6) (2024)
Francesco Gualdrini, Stefano Rizzieri, Sara Polletti, Francesco Pileri, Yinxiu Zhan, Alessandro Cuomo, Gioacchino Natoli
An integrative epigenome-based strategy for unbiased functional profiling of clinical kinase inhibitors. Molecular systems biology (2024)
Francesco Gualdrini, Stefano Rizzieri, Sara Polletti, Francesco Pileri, Yinxiu Zhan, Alessandro Cuomo, Gioacchino Natoli
An integrative epigenome-based strategy for unbiased functional profiling of clinical kinase inhibitors. Molecular systems biology 20 (6) (2024)
Francesco Gualdrini, Stefano Rizzieri, Sara Polletti, Francesco Pileri, Yinxiu Zhan, Alessandro Cuomo, Gioacchino Natoli
An integrative epigenome-based strategy for unbiased functional profiling of clinical kinase inhibitors. Molecular systems biology 20 (6) (2024)
Giovanni Ciriello, Luca Magnani, Sarah J Aitken, Leila Akkari, Sam Behjati, Douglas Hanahan, Dan A Landau, Núria López-Bigas, Darío G Lupiáñez, Jean-Christophe Marine, Ana Martin-Villalba, Gioacchino Natoli, Anna C Obenauf, Elisa Oricchio, Paola Scaffidi, Andrea Sottoriva, Alexander Swarbrick, Giovanni Tonon, Sakari Vanharanta, Johannes Zuber
Cancer Evolution: A Multifaceted Affair. Cancer discovery (2023)
Judith Barbara Zaugg, Pelin Sahlén, Robin Andersson, Meritxell Alberich-Jorda, Wouter de Laat, Bart Deplancke, Jorge Ferrer, Susanne Mandrup, Gioacchino Natoli, Dariusz Plewczyński, Álvaro Rada-Iglesias, Salvatore Spicuglia
Current challenges in understanding the role of enhancers in disease. Nature structural & molecular biology (2022)
Gabriele Alfarano, Matteo Audano, Pierluigi Di Chiaro, Chiara Balestrieri, Marta Milan, Sara Polletti, Paola Spaggiari, Alessandro Zerbi, Giuseppe Riccardo Diaferia, Nico Mitro, Gioacchino Natoli
Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells. Gut (2022)
Gioacchino Natoli, Francesco Pileri, Francesco Gualdrini, Serena Ghisletti
Integration of transcriptional and metabolic control in macrophage activation. EMBO reports 22 (9) (2021)
Liv M I Austenaa, Viviana Piccolo, Marta Russo, Elena Prosperini, Sara Polletti, Danilo Polizzese, Serena Ghisletti, Iros Barozzi, Giuseppe Riccardo Diaferia, Gioacchino Natoli
A first exon termination checkpoint preferentially suppresses extragenic transcription. Nature structural & molecular biology 28 (4) (2021)
Marta Milan, Giuseppe Riccardo Diaferia, Gioacchino Natoli
Tumor cell heterogeneity and its transcriptional bases in pancreatic cancer: a tale of two cell types and their many variants. The EMBO journal 40 (13) (2021)
Gioacchino Natoli, Renato Ostuni
Adaptation and memory in immune responses. Nature immunology 20 (7) (2019)
Marta Milan, Chiara Balestrieri, Gabriele Alfarano, Sara Polletti, Elena Prosperini, Paola Spaggiari, Alessandro Zerbi, Giuseppe R Diaferia, Gioacchino Natoli
FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner. The EMBO journal 38 (20) (2019)
Francesco Gualdrini, Gioacchino Natoli
Transcriptional repressors as guardians of tissue macrophage identity. The EMBO journal 38 (19) (2019)

Gioacchino Natoli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gioacchino Natoli